Upgrade to SI Premium - Free Trial

Tenax Therapeutics (TENX)

1.67 +0.04 (2.45%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/18/26)

Latest Headlines

Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: MILLENNIUM MANAGEMENT LLC October 15, 2026 5:29 PM - SEC Filing Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: SPHERA FUNDS MANAGEMENT LTD. October 13, 2026 6:05 AM - SEC Filing Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: Dellora Investments LP October 9, 2026 4:20 PM - SEC Filing Form 8-K TENAX THERAPEUTICS, INC. For: Oct 08 October 8, 2026 4:16 PM - SEC Filing Form 4 TENAX THERAPEUTICS, INC. For: Sep 16 Filed by: Doogan Declan September 17, 2026 9:30 PM - SEC Filing Form 4 TENAX THERAPEUTICS, INC. For: Sep 11 Filed by: Giordano Christopher Thomas September 15, 2026 9:39 PM - SEC Filing Form 4 TENAX THERAPEUTICS, INC. For: Sep 11 Filed by: STAAB THOMAS R II September 15, 2026 9:30 PM - SEC Filing Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: ING GROEP NV September 11, 2026 1:32 PM - SEC Filing Cantor Fitzgerald Reiterates Overweight Rating on Tenax Therapeutics (TENX) September 10, 2026 9:24 AM - StreetInsider Guggenheim Downgrades Tenax Therapeutics (TENX) to Neutral August 31, 2026 6:09 AM - StreetInsider Tenax shares Phase 3 LEVEL trial data at ESC Congress 2026 August 29, 2026 8:21 AM - StreetInsider Tenax Therapeutics Announces Presentation of Phase 3 LEVEL Results in Late-Breaking Scientific Sessions at ESC Congress 2026 August 29, 2026 8:21 AM - Globe NewsWire Form SCHEDULE 13G TENAX THERAPEUTICS, INC. Filed by: ING GROEP NV August 27, 2026 8:22 PM - SEC Filing Form SCHEDULE 13G TENAX THERAPEUTICS, INC. Filed by: SPHERA FUNDS MANAGEMENT LTD. August 27, 2026 6:20 AM - SEC Filing Form 4 TENAX THERAPEUTICS, INC. For: Aug 20 Filed by: Schneeberger Daniel August 24, 2026 6:13 PM - SEC Filing Form 3 TENAX THERAPEUTICS, INC. For: Aug 20 Filed by: Schneeberger Daniel August 24, 2026 5:51 PM - SEC Filing Form SCHEDULE 13G TENAX THERAPEUTICS, INC. Filed by: MILLENNIUM MANAGEMENT LLC August 18, 2026 7:09 PM - SEC Filing Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: Ikarian Capital, LLC August 14, 2026 9:15 PM - SEC Filing Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: PERCEPTIVE ADVISORS LLC August 14, 2026 5:25 PM - SEC Filing Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: Venrock Healthcare Capital Partners III, L.P. August 14, 2026 4:58 PM - SEC Filing Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: BIOTECHNOLOGY VALUE FUND L P August 14, 2026 4:31 PM - SEC Filing Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: Vivo Opportunity Fund Holdings, L.P. August 14, 2026 4:18 PM - SEC Filing Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: RTW INVESTMENTS, LP August 14, 2026 8:13 AM - SEC Filing Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: Adage Capital Management, L.P. August 12, 2026 12:06 PM - SEC Filing Tenax Therapeutics (TENX) PT Lowered to $4 at Guggenheim August 11, 2026 6:45 AM - StreetInsider Tenax Therapeutics (TENX) PT Lowered to $4 at Canaccord August 11, 2026 6:42 AM - StreetInsider Evercore ISI Downgrades Tenax Therapeutics (TENX) to In Line August 10, 2026 4:17 PM - StreetInsider William Blair Downgrades Tenax Therapeutics (TENX) to Market Perform August 10, 2026 12:50 PM - StreetInsider Tenax, Sionna plunge; MarineMax jumps premarket on reported buyout August 10, 2026 8:04 AM - StreetInsider Form 8-K TENAX THERAPEUTICS, INC. For: Aug 10 August 10, 2026 7:19 AM - SEC Filing Tenax Therapeutics Phase 3 trial of TNX-103 misses primary endpoint August 10, 2026 7:00 AM - StreetInsider Tenax Therapeutics Announces Topline Results from Phase 3 LEVEL Clinical Trial of TNX-103 in Patients with PH-HFpEF August 10, 2026 7:00 AM - Globe NewsWire Tenax Therapeutics (TENX) call put ratio 1 call to 2.4 puts on 15K contracts August 10, 2026 4:26 AM - StreetInsider Form SCHEDULE 13D/A TENAX THERAPEUTICS, INC. Filed by: Giordano Christopher Thomas July 31, 2026 4:16 PM - SEC Filing Form 10-Q TENAX THERAPEUTICS, INC. For: Jun 30 July 31, 2026 11:26 AM - SEC Filing Form 8-K TENAX THERAPEUTICS, INC. For: Jul 31 July 31, 2026 7:23 AM - SEC Filing Tenax Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update July 31, 2026 7:00 AM - Globe NewsWire Form SCHEDULE 13G TENAX THERAPEUTICS, INC. Filed by: BlackRock, Inc. July 30, 2026 11:19 AM - SEC Filing Canaccord Starts Tenax Therapeutics (TENX) at Buy July 28, 2026 7:21 AM - StreetInsider Full Article List